Vida Sana y Completa: A randomized controlled trial to examine the effectiveness of diabetes prevention with and without medically supportive groceries among Latina women

IF 2 3区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL
Lisa G. Rosas , Josselyn A. Perez , Wei-ting Chen , Lan Xiao , Patricia Rodriguez Espinosa , Elizabeth M. Venditti , Megan A. Lewis , Christopher D. Gardner , Alethea Marti , Erica Martinez , Maya Murthy , Michelle Hauser
{"title":"Vida Sana y Completa: A randomized controlled trial to examine the effectiveness of diabetes prevention with and without medically supportive groceries among Latina women","authors":"Lisa G. Rosas ,&nbsp;Josselyn A. Perez ,&nbsp;Wei-ting Chen ,&nbsp;Lan Xiao ,&nbsp;Patricia Rodriguez Espinosa ,&nbsp;Elizabeth M. Venditti ,&nbsp;Megan A. Lewis ,&nbsp;Christopher D. Gardner ,&nbsp;Alethea Marti ,&nbsp;Erica Martinez ,&nbsp;Maya Murthy ,&nbsp;Michelle Hauser","doi":"10.1016/j.cct.2024.107582","DOIUrl":null,"url":null,"abstract":"<div><p>Latina women have a high prevalence of obesity and obesity-related chronic diseases, such as diabetes. Approximately half of Latinas with obesity will also experience food insecurity, or a lack of access to enough food for an active and healthy life. Food insecurity is a barrier for effective prevention and management of obesity-related chronic diseases. The goal of this type 1 hybrid comparative effectiveness trial is to compare a culturally-tailored diabetes prevention intervention with and without medically supportive groceries. Adult Latina women (<em>n</em> = 412) with obesity (Body Mass Index (BMI) of &gt;30 kg/m<sup>2</sup>) and food insecurity will be 1:1 randomized to the Vida Sana intervention (control), or to Vida Sana y Completa (intervention plus integrated treatment for food insecurity). Vida Sana is an evidence-based culturally tailored, 12-month diabetes prevention intervention that targets at least 5% weight loss and at least 150 min/week of moderate-to-vigorous physical activity. Participants enrolled in Vida Sana y Completa will also receive 12 weekly deliveries of medically supportive groceries. Those in Vida Sana alone will receive information on local food resources. Participants will be assessed at baseline and every 6 months for 24 months. The primary outcome is weight loss at 12 months. Secondary outcomes include weight loss maintenance, diet quality, and quality of life. Barriers and facilitators of implementation will be assessed using mixed methods according to the Consolidated Framework for Implementation Research. This study will provide critical evidence for addressing the combination of obesity and food insecurity in primary care for diabetes prevention.</p><p><strong>Trial Registration</strong>: NCT052111.</p></div>","PeriodicalId":10636,"journal":{"name":"Contemporary clinical trials","volume":null,"pages":null},"PeriodicalIF":2.0000,"publicationDate":"2024-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Contemporary clinical trials","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1551714424001654","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Latina women have a high prevalence of obesity and obesity-related chronic diseases, such as diabetes. Approximately half of Latinas with obesity will also experience food insecurity, or a lack of access to enough food for an active and healthy life. Food insecurity is a barrier for effective prevention and management of obesity-related chronic diseases. The goal of this type 1 hybrid comparative effectiveness trial is to compare a culturally-tailored diabetes prevention intervention with and without medically supportive groceries. Adult Latina women (n = 412) with obesity (Body Mass Index (BMI) of >30 kg/m2) and food insecurity will be 1:1 randomized to the Vida Sana intervention (control), or to Vida Sana y Completa (intervention plus integrated treatment for food insecurity). Vida Sana is an evidence-based culturally tailored, 12-month diabetes prevention intervention that targets at least 5% weight loss and at least 150 min/week of moderate-to-vigorous physical activity. Participants enrolled in Vida Sana y Completa will also receive 12 weekly deliveries of medically supportive groceries. Those in Vida Sana alone will receive information on local food resources. Participants will be assessed at baseline and every 6 months for 24 months. The primary outcome is weight loss at 12 months. Secondary outcomes include weight loss maintenance, diet quality, and quality of life. Barriers and facilitators of implementation will be assessed using mixed methods according to the Consolidated Framework for Implementation Research. This study will provide critical evidence for addressing the combination of obesity and food insecurity in primary care for diabetes prevention.

Trial Registration: NCT052111.

Vida Sana y Completa:一项随机对照试验,旨在研究在拉丁裔妇女中使用或不使用医疗支持性食品杂货预防糖尿病的效果。
拉美裔女性肥胖和与肥胖相关的慢性疾病(如糖尿病)发病率很高。大约一半的拉美裔肥胖症患者也会面临食物不安全的问题,即无法获得足够的食物来维持积极健康的生活。粮食不安全是有效预防和控制肥胖相关慢性疾病的障碍。这项 1 类混合比较效果试验的目的是比较有无医疗支持性杂货的文化定制糖尿病预防干预措施。患有肥胖症(体重指数(BMI)大于 30 kg/m2)和食物无保障的拉丁裔成年女性(n = 412)将按 1:1 随机分配到 Vida Sana 干预方案(对照组)或 Vida Sana y Completa 方案(干预方案加食物无保障综合治疗)。Vida Sana 是一项以证据为基础、根据不同文化背景量身定制的为期 12 个月的糖尿病预防干预措施,目标是至少减轻 5%的体重,每周至少进行 150 分钟的中强度体育锻炼。参加 Vida Sana y Completa 的参与者每周还将收到 12 次医疗支持杂货配送。仅参加 Vida Sana 计划的参与者将获得有关当地食品资源的信息。参与者将在 24 个月内每 6 个月接受一次基线评估。主要结果是 12 个月时的体重减轻情况。次要结果包括保持体重、饮食质量和生活质量。将根据 "实施研究综合框架 "采用混合方法对实施的障碍和促进因素进行评估。这项研究将为在初级保健中解决肥胖和食物不安全问题以预防糖尿病提供重要证据。试验注册:NCT052111.
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.70
自引率
4.50%
发文量
281
审稿时长
44 days
期刊介绍: Contemporary Clinical Trials is an international peer reviewed journal that publishes manuscripts pertaining to all aspects of clinical trials, including, but not limited to, design, conduct, analysis, regulation and ethics. Manuscripts submitted should appeal to a readership drawn from disciplines including medicine, biostatistics, epidemiology, computer science, management science, behavioural science, pharmaceutical science, and bioethics. Full-length papers and short communications not exceeding 1,500 words, as well as systemic reviews of clinical trials and methodologies will be published. Perspectives/commentaries on current issues and the impact of clinical trials on the practice of medicine and health policy are also welcome.
文献相关原料
公司名称 产品信息 采购帮参考价格
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信